Tredje Ap Fonden Exact Sciences Corp Transaction History
Tredje Ap Fonden
- $10.7 Billion
- Q4 2024
A detailed history of Tredje Ap Fonden transactions in Exact Sciences Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 14,080 shares of EXAS stock, worth $642,329. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,080
Previous 28,160
50.0%
Holding current value
$642,329
Previous $1.92 Million
58.74%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$800 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$776 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$550 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$284 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$263 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.07B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...